The pooled estimate of the reviewed literature showed that ART patients with a CD4 count <200 cells/μL were 3.54 (1.12–11.21) times more at risk for infection with hepatitis B than those who had a CD4 count >500 cells/μL. This evidence concerns the gene CD4 and hepatitis B virus infection.